Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail
- PMID: 32901246
- PMCID: PMC7672528
- DOI: 10.1093/eurheartj/ehaa661
Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail
Figures
Comment on
-
Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention.Eur Heart J. 2020 Nov 1;41(41):3998-4007. doi: 10.1093/eurheartj/ehaa648. Eur Heart J. 2020. PMID: 32808014 Free PMC article.
References
-
- DeFilippis AP, Trainor P. When given a lemon, make lemonade: revising cardiovascular risk prediction scores. Ann Intern Med 2018;169:56–57. - PubMed
-
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;139:e1082–e1143. - PMC - PubMed
-
- Whelton PK, Carey RM, Aronow WS, DE Casey Jr, Collins KJ, Dennison, Himmelfarb C, DePalma SM, Gidding S,, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr., Spencer CC, Stafford RS, Taler SJ,, Thomas RJ, Williams KA Sr, Williamson JD, Jr., Wright JT 2017. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71:e127–e248. - PubMed
-
- Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI, Basu S. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med 2018;169:20–29. - PubMed
-
- Das SR, Everett BM, Birtcher KK, Brown JM, Cefalu WT, Januzzi JL Jr, Kalyani RR, Kosiborod M, Magwire ML, Morris PB, Sperling LS. 2018. ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 2018;72:3200–3223. - PMC - PubMed